Market Overview

ContraVir Pharmaceuticals Shares Up 29.6% Premarket After Co. Announced Preliminary Data From First Cohort Dosing In CRV431 Phase1/2a Trial Suggests Drug Is Safe And Well Tolerated; Drug Aims To Be All-Oral Functional Cure For Hepatitis B Virus

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: Movers Trading Ideas

 

Related Articles (CTRV)

Morgan Stanley Goes Neutral On BJ's Wholesale

Benzinga Pro's 5 Stocks To Watch Today